Cargando…

Histopathological Evidence of Thyroid Dermopathy and its Correlation with Thyroid-Associated Orbitopathy in Patients with Graves’ Disease having Normally Appearing Pretibial Skin: A Case-Control Study

OBJECTIVE: Thyroid dermopathy (TD), reportedly encountered in less than 5% of patients with Graves’ disease (GD), is supposed to coexist only with thyroid-associated orbitopathy (TAO). However, clinically inapparent TD, detected non-invasively by thermal imaging or ultrasonography, seems to be prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Abhijit, Chakraborty, Partha Pratim, Jana, Sayantan, Saha, Tarak Nath, Roy, Krishnendu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302423/
https://www.ncbi.nlm.nih.gov/pubmed/35873939
http://dx.doi.org/10.4103/ijem.ijem_504_21
_version_ 1784751632556228608
author Mishra, Abhijit
Chakraborty, Partha Pratim
Jana, Sayantan
Saha, Tarak Nath
Roy, Krishnendu
author_facet Mishra, Abhijit
Chakraborty, Partha Pratim
Jana, Sayantan
Saha, Tarak Nath
Roy, Krishnendu
author_sort Mishra, Abhijit
collection PubMed
description OBJECTIVE: Thyroid dermopathy (TD), reportedly encountered in less than 5% of patients with Graves’ disease (GD), is supposed to coexist only with thyroid-associated orbitopathy (TAO). However, clinically inapparent TD, detected non-invasively by thermal imaging or ultrasonography, seems to be present in a larger proportion of GD. Histopathological examination (HPE), though considered as gold standard for detecting TD, has not been performed widely to identify subclinical TD in GD. MATERIALS AND METHODS: In this single-centre, cross-sectional, case-control study, 50 patients with GD (cases) and normal appearing pretibial skin were compared with 45 age- and sex-matched individuals (39 healthy volunteers, 3 with toxic multinodular goitre and 3 with solitary toxic nodule) (control). All patients were evaluated clinically for presence of TAO. Punch biopsy specimens were obtained from the pretibial skin in all 95 participants. Tissue sections were examined under light microscopy for mucin deposition, splitting of collagen fibrils and perivascular lymphocytic infiltration. RESULTS: Sixty per cent of patients with GD demonstrated at least one of the above three histological features, while 52% had any combination of two features and 46% harboured all the three features. Mucin deposition, splitting of collagen fibrils and lymphocytic infiltration were found overall in 52%, 54% and 52% of GD, respectively; 4.4–11.1% of controls also had some evidence of TD on HPE. Subclinical TD was not related to age, duration of disease and TAO in our study. CONCLUSIONS: TD, particularly in its subclinical form, Seems to be widely prevalent in GD (46–60%) and exists even in absence of TAO. HPE, though more sensitive than the various non-invasive tests, is not specific (ranges from 89% to 95%) for TD. However, HPE can accurately diagnose TD in appropriate clinical background.
format Online
Article
Text
id pubmed-9302423
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-93024232022-07-22 Histopathological Evidence of Thyroid Dermopathy and its Correlation with Thyroid-Associated Orbitopathy in Patients with Graves’ Disease having Normally Appearing Pretibial Skin: A Case-Control Study Mishra, Abhijit Chakraborty, Partha Pratim Jana, Sayantan Saha, Tarak Nath Roy, Krishnendu Indian J Endocrinol Metab Original Article OBJECTIVE: Thyroid dermopathy (TD), reportedly encountered in less than 5% of patients with Graves’ disease (GD), is supposed to coexist only with thyroid-associated orbitopathy (TAO). However, clinically inapparent TD, detected non-invasively by thermal imaging or ultrasonography, seems to be present in a larger proportion of GD. Histopathological examination (HPE), though considered as gold standard for detecting TD, has not been performed widely to identify subclinical TD in GD. MATERIALS AND METHODS: In this single-centre, cross-sectional, case-control study, 50 patients with GD (cases) and normal appearing pretibial skin were compared with 45 age- and sex-matched individuals (39 healthy volunteers, 3 with toxic multinodular goitre and 3 with solitary toxic nodule) (control). All patients were evaluated clinically for presence of TAO. Punch biopsy specimens were obtained from the pretibial skin in all 95 participants. Tissue sections were examined under light microscopy for mucin deposition, splitting of collagen fibrils and perivascular lymphocytic infiltration. RESULTS: Sixty per cent of patients with GD demonstrated at least one of the above three histological features, while 52% had any combination of two features and 46% harboured all the three features. Mucin deposition, splitting of collagen fibrils and lymphocytic infiltration were found overall in 52%, 54% and 52% of GD, respectively; 4.4–11.1% of controls also had some evidence of TD on HPE. Subclinical TD was not related to age, duration of disease and TAO in our study. CONCLUSIONS: TD, particularly in its subclinical form, Seems to be widely prevalent in GD (46–60%) and exists even in absence of TAO. HPE, though more sensitive than the various non-invasive tests, is not specific (ranges from 89% to 95%) for TD. However, HPE can accurately diagnose TD in appropriate clinical background. Wolters Kluwer - Medknow 2022 2022-06-06 /pmc/articles/PMC9302423/ /pubmed/35873939 http://dx.doi.org/10.4103/ijem.ijem_504_21 Text en Copyright: © 2022 Indian Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Mishra, Abhijit
Chakraborty, Partha Pratim
Jana, Sayantan
Saha, Tarak Nath
Roy, Krishnendu
Histopathological Evidence of Thyroid Dermopathy and its Correlation with Thyroid-Associated Orbitopathy in Patients with Graves’ Disease having Normally Appearing Pretibial Skin: A Case-Control Study
title Histopathological Evidence of Thyroid Dermopathy and its Correlation with Thyroid-Associated Orbitopathy in Patients with Graves’ Disease having Normally Appearing Pretibial Skin: A Case-Control Study
title_full Histopathological Evidence of Thyroid Dermopathy and its Correlation with Thyroid-Associated Orbitopathy in Patients with Graves’ Disease having Normally Appearing Pretibial Skin: A Case-Control Study
title_fullStr Histopathological Evidence of Thyroid Dermopathy and its Correlation with Thyroid-Associated Orbitopathy in Patients with Graves’ Disease having Normally Appearing Pretibial Skin: A Case-Control Study
title_full_unstemmed Histopathological Evidence of Thyroid Dermopathy and its Correlation with Thyroid-Associated Orbitopathy in Patients with Graves’ Disease having Normally Appearing Pretibial Skin: A Case-Control Study
title_short Histopathological Evidence of Thyroid Dermopathy and its Correlation with Thyroid-Associated Orbitopathy in Patients with Graves’ Disease having Normally Appearing Pretibial Skin: A Case-Control Study
title_sort histopathological evidence of thyroid dermopathy and its correlation with thyroid-associated orbitopathy in patients with graves’ disease having normally appearing pretibial skin: a case-control study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302423/
https://www.ncbi.nlm.nih.gov/pubmed/35873939
http://dx.doi.org/10.4103/ijem.ijem_504_21
work_keys_str_mv AT mishraabhijit histopathologicalevidenceofthyroiddermopathyanditscorrelationwiththyroidassociatedorbitopathyinpatientswithgravesdiseasehavingnormallyappearingpretibialskinacasecontrolstudy
AT chakrabortyparthapratim histopathologicalevidenceofthyroiddermopathyanditscorrelationwiththyroidassociatedorbitopathyinpatientswithgravesdiseasehavingnormallyappearingpretibialskinacasecontrolstudy
AT janasayantan histopathologicalevidenceofthyroiddermopathyanditscorrelationwiththyroidassociatedorbitopathyinpatientswithgravesdiseasehavingnormallyappearingpretibialskinacasecontrolstudy
AT sahataraknath histopathologicalevidenceofthyroiddermopathyanditscorrelationwiththyroidassociatedorbitopathyinpatientswithgravesdiseasehavingnormallyappearingpretibialskinacasecontrolstudy
AT roykrishnendu histopathologicalevidenceofthyroiddermopathyanditscorrelationwiththyroidassociatedorbitopathyinpatientswithgravesdiseasehavingnormallyappearingpretibialskinacasecontrolstudy